K-numberK252711
Device nameAdvantage-C™ Ti3D Cervical Interbody Fusion Device
ApplicantIntelivation Technologies
Product codeODP
Device classClass II
Decision dateJan 8, 2026
DecisionSubstantially Equivalent
Regulation888.3080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Advantage-C Ti3D Cervical Interbody Fusion Device is a cervical spine implant made of titanium alloy for treating degenerative disc disease in one vertebral level (C2-T1) in skeletally mature patients. It features a central graft window for autogenous bone graft and is used with supplemental fixation systems.

Technological characteristics

The device is additively manufactured from medical-grade titanium Ti-6Al-4V ELI (ASTM F3001-14) in various sizes, footprints, heights, and lordotic angles. It introduces no new technological characteristics compared to predicates; material composition and manufacturing methods are consistent with the Ti3Z predicate device, and intended use matches the PEEK predicate.

Test standards cited

ASTM F2077 (static and dynamic axial compression, static and dynamic torsion), ASTM F2267 (static subsidence), and static expulsion testing. Testing was conducted in accordance with FDA Guidance and relevant ASTM standards.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →